background
cryptosporidium
parvum
major
caus
diarrhea
children
rumin
earliest
stage
life
matern
antibodi
repres
main
shield
neonat
mammal
infect
two
recombin
antigen
portion
two
c
parvum
protein
test
abil
induc
immun
respons
adult
mice
protect
neonat
balbc
mice
born
femal
immunis
mucos
deliveri
peptid
adult
balbc
mice
intraperiton
immunis
separ
mix
immun
respons
characteris
furthermor
balbc
pregnant
mice
immunis
mucos
deliveri
mix
pregnanc
soon
birth
offspr
infect
two
dose
c
parvum
oocyst
parasit
burden
determin
day
postinfect
intraperiton
immunis
induc
specif
igg
serum
specif
iga
intestin
mucosa
increas
cell
splenocyt
produc
neonat
born
immunis
mice
infect
oocyst
show
signific
reduct
oocyst
intestin
form
respect
reduct
parasit
form
p
observ
neonat
infect
oocyst
conclus
peptid
induc
specif
humor
cellmedi
immun
respons
c
parvum
adult
mice
moreov
mucos
administr
mix
pregnant
mice
reduc
c
parvum
burden
litter
cryptosporidium
genu
includ
speci
infect
wide
rang
vertebr
includ
mani
mammal
human
also
suscept
parasit
domest
wild
rumin
particularli
livestock
repres
import
sourc
zoonot
transmiss
mammal
cryptosporidium
spp
mainli
affect
gut
caus
gastrointestin
symptom
diarrhoea
approxim
human
infect
caus
cryptosporidium
parvum
cryptosporidium
homini
although
speci
infect
human
immunocompet
patient
cryptosporidiosi
selflimit
infect
small
intestin
caus
wateri
diarrhoea
last
ten
day
wherea
infect
becom
chronic
lifethreaten
diseas
immunocompromis
individu
aid
subject
parasit
vector
correspond
fabiotosini
issit
mariaangelesgomezmoral
issit
european
union
refer
laboratori
parasit
istituto
superior
di
rome
itali
transmiss
occur
via
faecalor
rout
ingest
oocyst
contamin
food
water
oocyst
highli
resist
environment
condit
chlorin
sterilis
treatment
contamin
water
plant
therefor
caus
massiv
outbreak
follow
food
agricultur
organis
world
health
organis
consid
protozoa
genu
cryptosporidium
one
signific
foodborn
parasit
livestock
husbandri
c
parvum
major
caus
sever
diarrhoea
among
neonat
calv
lamb
result
substanti
cost
farmer
recent
studi
diarrhoea
conduct
calv
younger
one
month
report
c
parvum
respons
sole
agent
diarrhoeal
infect
coinfect
intestin
pathogen
recent
year
infect
c
parvum
c
homini
emerg
signific
caus
infantil
diarrhoea
extend
casecontrol
studi
refer
global
enter
multicent
studi
gem
shown
high
preval
cryptosporidium
spp
among
children
develop
countri
rank
protozoa
among
four
pathogen
respons
major
diarrhoea
case
children
younger
five
year
preval
parasit
higher
infant
age
less
month
age
rang
cryptosporidium
spp
second
common
caus
death
associ
diarrhoea
rotaviru
suscept
neonat
children
cryptosporidium
spp
complet
understood
nurs
period
innat
immun
respons
enterocyt
usual
trigger
stimul
tolllik
receptor
almost
complet
inhibit
favour
establish
commens
flora
gut
given
immun
respons
cryptosporidium
spp
begin
stimul
consequ
activ
nfkappa
b
pathway
temporari
inhibit
innat
enterocyt
respons
could
promot
prolifer
dissemin
cryptosporidium
spp
neonat
intestin
present
nitazoxanid
drug
approv
cryptosporidiosi
us
food
drug
administr
usfda
drug
use
children
younger
one
year
ineffect
immunodefici
patient
vaccin
cryptosporidiosi
yet
avail
immun
protect
neonat
difficult
achiev
earlyag
immun
statu
howev
variou
cryptosporidium
spp
protein
particularli
consid
virul
factor
propos
possibl
vaccin
candid
context
passiv
immunis
neonat
might
altern
convent
vaccin
inde
passiv
immun
provid
hyperimmun
bovin
colostrum
shown
establish
appreci
level
protect
human
patient
aidsassoci
cryptosporidiosi
recent
protect
role
matern
anticryptosporidium
antibodi
demonstr
two
natur
context
survey
child
cohort
bangladesh
report
presenc
anticryptosporidium
iga
breast
milk
protect
neonat
cryptosporidiosi
second
studi
conduct
endem
area
tanzania
cohort
breastfeed
mother
infant
month
shown
infect
rate
increas
reduct
matern
milk
ingest
studi
investig
feasibl
immunolog
prevent
treatment
imped
reduc
cryptosporidiosi
newborn
mammal
preliminari
step
two
recombin
antigen
inocul
adult
mice
achiev
onset
specif
immun
respons
group
femal
mice
immunis
mucos
deliveri
antigen
prior
pregnanc
parallel
control
group
treat
adjuv
offspr
mice
infect
two
differ
dose
c
parvum
oocyst
parasit
burden
measur
flow
cytometri
microscop
count
quantit
pcr
assay
result
indic
neonat
born
immunis
mother
reduc
parasit
load
compar
neonat
born
control
mice
cryptosporidium
parvum
oocyst
isol
code
collect
faec
experiment
infect
calv
purifi
centrifug
sucros
percol
sigmaaldrich
saint
loui
mo
usa
densitygradi
cryptosporidium
parvumcrud
extract
cce
obtain
previous
describ
heatlabil
enterotoxin
lt
obtain
chiron
spa
siena
itali
ketavet
xylazin
solut
provid
anim
care
unit
istituto
superior
di
rome
itali
rabbit
antic
parvum
igg
polyclon
antibodi
recognis
stage
c
parvum
use
ifa
assay
recombin
peptid
mw
kda
mw
kda
repres
antigen
portion
two
micronem
protein
c
parvum
name
respect
protein
id
code
refer
sequenc
cryptodb
databas
releas
two
peptid
purifi
previous
describ
dialys
phosphat
buffer
salin
pb
plu
glycerol
store
aliquot
peptid
use
sole
immunis
agent
mixtur
two
antigen
refer
hereaft
mix
eightto
tenweekold
balbc
femal
mice
charl
river
laboratori
milan
itali
hous
anim
care
unit
istituto
superior
di
accord
european
direct
vivo
protocol
approv
italian
ministri
health
approv
januari
three
group
five
femal
mice
immunis
intraperiton
one
group
second
group
third
group
mix
plu
respect
control
group
n
inject
equal
volum
pb
instead
antigen
accord
immunis
schedul
follow
day
peptid
pb
administ
freund
complet
adjuv
sigmaaldrich
day
amount
peptid
pb
inocul
use
freund
incomplet
adjuv
sigmaaldrich
day
last
booster
provid
use
quantiti
peptid
pb
without
adjuv
mice
bled
day
follow
initi
immunis
individu
sera
store
faecal
sampl
iga
assay
collect
weekli
mous
separ
weigh
dissolv
ml
pb
sodium
azid
per
mg
faecal
materi
cocktail
proteas
inhibitor
sigmaaldrich
ad
ratio
sampl
sampl
vortex
min
centrifug
remov
debri
supernat
collect
store
level
igg
iga
serum
sampl
iga
faecal
sampl
specif
c
parvum
determin
elisa
level
igg
iga
specif
peptid
also
determin
elisa
microtit
plate
nuncimmuno
plate
polysorp
sigmaaldrich
roskild
denmark
block
use
per
well
wv
bsa
pb
room
temperatur
rt
min
coat
recombin
peptid
cce
mm
carbonatebicarbon
buffer
ph
incub
min
serum
sampl
dilut
pb
wv
bsa
vv
supernat
faecal
sampl
dilut
describ
plate
wash
three
time
pb
incub
sera
wash
repeat
incub
use
conjug
antibodi
dilut
sera
faecal
supernat
establish
optim
work
condit
dilut
ad
duplic
well
incub
overnight
neg
control
correspond
preimmun
faecal
serum
sampl
mous
use
dilut
elisa
bound
antibodi
detect
incub
dilut
biotinconjug
rat
monoclon
antimous
igg
iga
antibodi
bd
pharmingen
tm
san
diego
ca
usa
rt
h
follow
mgml
avidinperoxidas
sigmaaldrich
min
peroxidas
substrat
tmb
kierkegaard
perri
laboratori
gaithersburg
md
usa
ad
well
optic
densiti
measur
multiskan
spectrum
elisa
reader
thermo
scientif
vantaa
finland
nm
elisa
perform
isotyp
use
protocol
end
immunis
schedul
mice
sacrif
spleen
harvest
steril
condit
disrupt
use
syring
erythrocyt
lyse
splenocyt
suspend
complet
medium
contain
foetal
bovin
serum
mm
hepe
mm
lglutamin
uml
penicillin
streptomycin
mm
sodium
pyruv
mm
nonessenti
amino
acid
hyclon
laboratori
logan
ut
usa
final
cell
concentr
prolifer
analysi
cellsml
cell
settl
flatbottom
plate
costar
corpor
cambridg
usa
cytokin
phenotyp
analysi
cell
suspend
cell
ml
ml
tube
becton
dickinson
franklin
lake
nj
usa
cell
cultur
stimul
cce
incub
co
five
day
cell
cultur
neg
control
grown
without
stimul
wherea
posit
control
cell
stimul
concanavalin
lymphocyt
prolifer
measur
h
cultur
hthymidin
incorpor
presenc
h
thymidin
amersham
life
scienc
buckinghamshir
uk
sampl
triplic
prolifer
express
stimul
index
si
ie
count
per
minut
ccestimul
cell
divid
count
per
minut
unstimul
cell
si
consid
posit
cytokin
analysi
cultur
supernat
harvest
five
day
cultur
store
assay
cytokin
level
measur
cultur
supernat
elisa
essenti
plate
nuncimmuno
tm
plate
maxisorp
tm
surfac
sigmaaldrich
roskild
denmark
coat
solut
na
hpo
ph
monoclon
rat
antimous
cytokin
antibodi
bd
pharmingen
overnight
incub
plate
wash
pbst
block
bsa
sigmaaldrich
pb
h
wash
serial
dilut
cultur
supernat
standard
ie
recombin
mous
cytokin
ad
well
incub
overnight
plate
wash
appropri
biotinconjug
rat
antimous
cytokin
antibodi
bd
pharmingen
ad
well
incub
h
wash
addit
hrpconjug
streptavidin
bd
pharmingen
h
tmb
kirkegaard
perri
laboratori
substrat
ad
well
absorb
measur
nm
min
standard
curv
gener
cytokin
use
correspond
murin
recombin
standard
minimum
detect
level
cytokin
elisa
pgml
pgml
pg
ml
analys
lymphocyt
subset
incub
cce
splenocyt
suspens
mous
wash
pb
contain
bsa
resuspend
buffer
cell
incub
follow
fluorescein
isothiocyan
fitc
phycoerythrin
pe
conjug
monoclon
antibodi
murin
leukocyt
differenti
molecul
bd
pharmingen
cell
analys
singl
dual
fluoresc
assay
fluorescenceactiv
cellsort
facscalibur
becton
dickinson
franklin
lake
nj
usa
data
acquir
cellquest
softwar
becton
dickinson
instrument
set
measur
fluoresc
intens
forwardangl
light
scatter
fsc
sideangl
light
scatter
ssch
fitc
pe
fitc
cell
incub
fitcand
peconjug
mous
serv
isotyp
control
proport
cell
express
given
molecul
determin
averag
three
replica
two
group
experiment
control
group
five
mice
anaesthetis
ketavet
mgml
xylazin
mgml
mgkg
mgkg
respect
mice
experiment
group
immunis
intranas
pb
contain
lt
mix
wherea
mice
control
group
inocul
intranas
pb
contain
lt
seven
day
immunis
protocol
repeat
bed
cage
hous
male
mice
transfer
cage
hous
femal
h
induc
oestru
subsequ
one
male
two
femal
kept
cage
h
femal
examin
daili
presenc
copulatori
plug
day
plug
detect
assum
day
pregnanc
immunis
repeat
day
pregnanc
fig
blood
sampl
taken
tail
bleed
day
initi
immunis
individu
sera
store
analysi
faecal
sampl
collect
time
treat
store
describ
specif
igg
iga
c
parvum
measur
serum
faecal
sampl
elisa
prolifer
assay
phenotyp
analysi
spleen
cell
perform
describ
studi
protect
induc
mucos
immunis
six
litter
threedayold
balbc
mice
mice
use
two
litter
born
mother
immunis
intranas
lt
infect
oocyst
sacrif
five
nine
day
postinfect
pi
respect
anoth
litter
born
intranas
immunis
mother
infect
oocyst
sacrif
nine
day
pi
remain
three
litter
respect
control
group
suckl
mice
experiment
infect
oral
rout
use
oocyst
suspend
pb
gavag
needl
kept
mother
suckl
mice
anaesthetis
euthanasia
whole
intestin
collect
lymphocyt
phenotyp
analysi
perform
spleen
mice
born
intranas
immunis
mother
infect
oocyst
sacrif
five
day
later
entir
intestin
content
collect
wash
intestin
tract
pb
sampl
vortex
paus
supernat
centrifug
min
pellet
contain
oocyst
free
form
parasit
suspend
ml
pb
vortex
sampl
divid
two
aliquot
one
aliquot
test
immunofluoresc
assay
ie
flow
cytometri
indirect
immunofluoresc
assay
ifa
wherea
second
aliquot
use
extract
dna
qpcr
see
use
flow
cytometri
number
oocyst
faecal
sampl
evalu
use
acquisit
gate
base
forwardangl
light
scatter
fsch
characterist
fluoresc
intens
fitc
detector
posit
control
posit
control
consist
oocyst
suspens
pb
incub
antic
parvum
igg
flow
cytometri
analysi
perform
three
time
mous
number
oocyst
express
mean
sd
mous
group
intracellular
parasit
count
ileum
homogen
mous
homogenis
carri
individu
ml
pb
min
use
potter
homogenis
dilut
pb
suspens
filter
use
filcon
syring
beckton
dickinson
incub
antic
parvum
igg
antirabbit
fitc
antibodi
min
rt
intracellular
parasit
count
use
flow
cytometri
number
intracellular
stage
express
mean
sd
mous
group
signific
differ
experiment
control
group
found
number
oocyst
also
evalu
use
ifa
see
ifa
oocyst
suspens
mix
solut
antic
parvum
igg
pb
mixtur
kept
dark
min
centrifug
ten
min
pellet
resuspend
ml
pb
antirabbit
fitc
antibodi
ad
sampl
kept
dark
min
centrifug
min
pellet
suspend
ml
pb
transfer
polystyren
tube
kept
sampl
analys
day
oocyst
collect
number
oocyst
evalu
fluoresc
microscopi
zeiss
axioplan
carl
zeiss
jena
germani
magnif
wash
see
intestin
mice
infect
oocyst
fix
formaldehyd
pb
h
histolog
examin
perform
use
follow
procedur
ileum
portion
cut
wash
tap
water
overnight
dehydr
increas
concentr
ethanol
place
xylol
final
includ
paraffin
paraffin
tissu
cut
use
leica
rt
microtom
leica
biosystem
nussloch
germani
microscop
slice
distribut
microscop
slide
dri
overnight
slice
deparaffin
immers
xylol
min
rehydr
decreas
concentr
ethanol
final
wash
distil
water
min
antigen
retriev
fix
tissu
perform
use
follow
pressur
cook
protocol
microscop
slide
place
stainless
steel
slide
rack
boil
citrat
buffer
mm
sodium
citrat
tween
ph
pressur
cooker
heat
hot
plate
lid
close
steam
high
pressur
pan
rapidli
cool
use
run
tap
water
lid
immedi
slide
prepar
indirect
immunofluoresc
assay
ifa
block
use
foetal
calf
serum
fc
pb
h
room
temperatur
incub
h
antic
parvum
rabbit
serum
dilut
fc
pb
wash
three
time
wash
pb
remov
unbound
antibodi
secondari
incub
conduct
h
room
temperatur
use
goat
antirabbit
antibodi
conjug
fluorescein
fitc
biorad
hercul
ca
usa
dilut
fc
pb
slide
wash
seal
use
prolong
antifad
thermo
fisher
scientif
waltham
usa
microscop
inspect
tissu
slice
conduct
use
fluoresc
microscop
zeiss
axioplan
magnif
digit
imag
obtain
use
axiovis
softwar
carl
zeiss
qpcr
aliquot
whole
intestin
content
mice
infect
oocyst
see
centrifug
suspend
ml
ethanol
pb
store
dna
extract
aliquot
centrifug
wash
pb
resuspend
lysi
buffer
mm
dtt
mgml
proteinas
k
pb
transfer
plate
incub
h
autom
extract
plate
transfer
biosprint
apparatu
qiagen
hilden
germani
use
protocol
blood
sampl
oneforal
vet
kit
reagent
qiagen
dna
elut
final
volum
dna
also
extract
way
referenc
dilut
purifi
oocyst
triplic
obtain
sampl
theoret
oocyst
use
standard
curv
base
median
cross
threshold
ct
qpcr
experi
dna
sampl
infect
mice
referenc
dilut
analys
use
realtim
pcr
assay
qpcr
base
cowp
gene
assay
test
sensit
use
refer
sampl
obtain
posit
curv
singl
oocyst
ct
three
three
replica
theoret
oocyst
ct
one
three
replica
sampl
produc
less
ct
consid
posit
cowp
primer
synthesis
primm
milan
itali
taqman
probe
cowp
probe
label
hex
em
nm
tib
molbiol
berlin
germani
pcr
reaction
complet
final
volum
compris
lightcycl
probe
master
mix
contain
faststart
taq
dna
polymeras
proprietari
buffer
includ
deoxynucleotid
triphosph
dntp
mgcl
final
concentr
mm
nm
primer
nm
taqman
probe
whole
intestin
content
dna
sampl
reaction
perform
plate
lightcycl
pcr
system
roch
diagnost
mannheim
germani
triplic
three
neg
control
includ
plate
pcr
condit
min
incub
follow
cycl
min
fluoresc
data
three
data
realtim
point
collect
end
cycl
compar
experiment
group
relev
control
group
mannwhitney
utest
use
pvalu
consid
signific
ip
immunis
adult
balbc
mice
singl
antigen
mixtur
two
antigen
mix
induc
specif
anticryptosporidium
igg
serum
day
follow
initi
administr
later
level
specif
igg
progress
increas
time
reach
highest
respons
day
initi
immunis
u
fig
expect
sera
mice
immunis
mix
react
respect
homolog
antigen
elisa
data
shown
specif
anticryptosporidium
iga
detect
faec
day
initi
immunis
last
sampl
day
three
antigen
formul
u
z
p
mix
fig
specif
iga
respons
detect
faec
day
control
mice
cce
induc
prolifer
splenocyt
mix
ip
immunis
mice
highest
respons
cce
obtain
splenocyt
mice
immunis
alon
mix
splenocyt
immunis
control
mice
respond
concanavalin
singl
peptid
also
induc
prolifer
splenocyt
mice
immunis
homolog
peptid
fig
cce
induc
product
splenocyt
group
immunis
mice
splenocyt
mice
immunis
produc
higher
level
stimul
homolog
peptid
mice
immunis
mix
stimul
mix
product
observ
mous
group
highest
level
product
observ
splenocyt
mice
immunis
minim
basal
product
detect
spleen
cell
group
immunis
mice
tabl
induc
cell
popul
splenocyt
analys
day
initi
immunis
percentag
cell
similar
mice
immunis
mix
significantli
higher
nonimmunis
control
mice
howev
percentag
cell
similar
among
group
includ
control
moreov
percentag
activ
lymphocyt
coexpress
high
affin
receptor
decreas
immunis
group
particularli
immunis
group
u
z
p
fig
mucos
deliveri
mix
femal
balbc
mice
induc
specif
anticryptosporidium
igg
mainli
serum
day
initi
immunis
igg
level
increas
time
day
day
high
igg
level
detect
last
observ
day
versu
control
group
u
z
p
igg
fig
b
low
specif
iga
level
detect
serum
end
experi
day
initi
immunis
fig
faec
specif
anticryptosporidium
igg
iga
began
increas
day
follow
first
deliveri
time
versu
control
group
u
z
p
u
z
p
igg
iga
respect
specif
igg
iga
respons
detect
faec
day
control
mice
fig
e
cce
cona
induc
prolifer
splenocyt
mice
immunis
intranas
mix
splenocyt
control
mice
respond
concanavalin
fig
cytometr
analysi
perform
ccestimul
splenocyt
adult
mice
immunis
intranas
litter
spleen
harvest
adult
mice
day
follow
initi
immunis
percentag
cell
increas
adult
mice
treat
mix
result
obtain
ccestimul
splenocyt
passiv
immunis
litter
infect
oocyst
tabl
infect
oocyst
passiv
immunis
suckl
mice
show
similar
level
reduct
day
day
follow
infect
particular
signific
reduct
excret
oocyst
u
z
p
intracellular
form
u
z
p
ileum
observ
use
flow
cytometri
fig
infect
neonat
also
undertaken
lower
dose
oocyst
order
get
closer
natur
infect
dose
use
oocyst
histolog
examin
ileum
infect
mice
show
evid
infect
ie
parasitophor
vacuol
analys
section
neonat
born
immunis
femal
fig
contrast
newborn
nonimmunis
femal
numer
parasitophor
vacuol
dissemin
along
epitheli
line
intestin
lumen
fig
inde
quantit
analysi
entir
intestin
content
day
pi
show
strike
reduct
parasit
newborn
immunis
femal
u
z
p
evalu
microscop
count
ifa
fig
confirm
overal
reduct
parasit
form
passiv
immunis
newborn
mice
infect
lower
infect
dose
ie
oocyst
intestin
content
newborn
evalu
use
realtim
qpcr
assay
shown
fig
ct
valu
faecal
sampl
suckl
mice
born
immunis
mother
rang
ie
equival
oocyst
four
sampl
show
ct
valu
higher
thu
less
one
oocyst
equival
content
ct
valu
control
mice
rang
ie
equival
oocyst
therefor
qpcr
analysi
confirm
parasit
load
intestin
content
newborn
immunis
mother
extrem
low
newborn
infect
lower
dose
oocyst
control
neonat
cryptosporidiosi
challeng
task
lack
appropri
drug
difficulti
provid
effect
immunis
earli
phase
life
explor
protect
effect
antic
parvum
matern
antibodi
transfer
newborn
placenta
gestat
colostrum
first
day
life
end
two
recombin
peptid
first
immunolog
characteris
ip
inject
adult
mice
evalu
potenti
immunogen
peptid
separ
mix
formul
induc
specif
igg
iga
respons
peptid
previous
describ
immunodomin
antigen
involv
mainten
tcell
respons
healthi
c
parvumsensitis
individu
import
note
amino
acid
sequenc
peptid
show
similar
mammalian
protein
contrast
also
highli
conserv
cryptosporidium
speci
particularli
human
pathogen
data
shown
therefor
like
antibodi
also
react
strictli
relat
protein
c
homini
c
ubiquitum
studi
demonstr
ip
immunis
recombin
peptid
abl
support
effect
cellmedi
immun
respons
specif
stimuli
cce
specif
prolifer
splenocyt
immunis
adult
mice
howev
maximum
prolif
respons
cce
obtain
splenocyt
mice
follow
ip
immunis
mix
fig
induc
cell
popul
show
higher
percentag
cell
express
moreov
splenocyt
mice
immunis
show
signific
reduct
percentag
regulatori
cell
compar
control
group
wherea
other
fig
overal
three
antigen
formul
mix
induc
lesser
extent
immunis
mice
tabl
noteworthi
stimul
homolog
antigen
result
highest
level
product
cytokin
even
splenocyt
also
respond
stimul
cce
tabl
experiment
studi
clinic
case
demonstr
activ
lymphocyt
product
crucial
parasit
clearanc
inde
product
one
essenti
function
cell
respons
cryptosporidium
antigen
regard
humor
respons
three
antigen
formul
mix
induc
specif
igg
secretori
iga
fig
product
transfer
antibodi
fundament
requir
confer
protect
immun
neonat
therefor
antigen
mix
use
mucos
immunis
femal
mice
order
evalu
protect
effect
offspr
note
adult
femal
balbc
mice
mucos
immunis
mix
cell
stimul
c
parvum
crude
extract
gate
analysi
splenocyt
adult
mice
carri
last
day
experi
number
mice
shown
fig
newborn
mice
born
intranas
immunis
mother
infect
oocyst
sacrif
five
day
later
comparison
c
parvuminfect
litterm
born
immunis
mother
respect
control
ie
c
parvuminfect
litterm
born
mother
immunis
use
mucos
adjuv
show
matern
protect
highli
effect
lower
infect
dose
sinc
reduct
parasit
burden
fig
adult
femal
mucos
immunis
mix
lead
longlast
week
humor
respons
system
intestin
level
fig
moreov
splenocyt
balbc
mother
specif
prolifer
respons
cce
result
popul
show
increas
percentag
cell
tabl
experiment
infect
neonat
mice
born
immunis
mother
show
neonat
infect
massiv
dose
oocyst
protect
effect
progeni
measur
ineffect
excret
oocyst
convers
drastic
reduct
oocyst
emiss
observ
neonat
infect
lower
dose
oocyst
still
repres
huge
amount
given
small
weight
g
newborn
mice
fig
fact
dose
compar
dose
oocyst
kg
human
oocyst
number
test
first
instanc
allow
quantit
analysi
excret
oocyst
parasit
form
use
flow
cytometri
although
dose
yield
parasit
amount
sensit
threshold
instrument
overcom
technic
limit
ifamicroscop
count
qpcr
use
evalu
minim
quantiti
parasit
infect
mice
moreov
dna
sampl
qpcr
prepar
use
adhoc
autom
method
order
reduc
handl
error
cellmedi
immun
show
unexpect
sign
activ
splenocyt
harvest
litter
immunis
mother
increas
percentag
cell
well
cell
tabl
similarli
tcell
respons
identifi
matern
vaccin
newborn
mice
plasmodium
yoelii
model
although
parallel
increas
antibodi
respons
recent
studi
indic
pregnanc
matern
molecul
inflammatori
cytokin
well
microbi
product
transfer
utero
foetu
influenc
foetal
immun
system
thu
neonat
host
may
compens
insuffici
adapt
immun
respons
heighten
capac
mount
certain
type
innat
immun
respons
attempt
passiv
immunis
administr
hyperimmun
colostrum
perform
human
mammal
inde
hyperimmun
bovin
colostrum
given
aid
patient
prolong
cryptosporidiosi
result
reduct
diarrhoea
improv
symptom
livestock
passiv
immunis
recombin
antigen
shown
certain
efficaci
protect
passiv
immunis
calv
kid
recent
heterolog
protect
also
success
test
administr
hyperimmun
ovin
colostrum
neonat
mice
unlik
previou
studi
studi
combin
use
mixtur
two
defin
antigen
extens
characteris
immunogen
peculiar
studi
mucos
immunis
femal
confer
protect
progeni
matern
immunis
protocol
pathogen
appli
success
prevent
neonat
infecti
diseas
variou
context
regard
livestock
vaccin
rotaviru
coronaviru
escherichia
coli
rotaveccorona
msd
commonli
use
immunis
heifer
preparturi
cow
treatment
induc
higher
titr
specif
antibodi
pathogen
colostrum
milk
signific
efficaci
reduc
diarrhoea
neonat
calv
human
matern
immunis
tetanu
toxoid
fig
quantif
cowp
gene
dna
copi
qpcr
intestin
content
neonat
mice
infect
cryptosporidium
parvum
oocyst
valu
express
mean
cycl
cross
threshold
ct
sampl
test
triplic
standard
curv
black
dot
obtain
dna
extract
follow
oocyst
dilut
blue
dot
repres
ct
valu
control
mice
red
dot
repres
ct
valu
immunis
mice
valu
control
mice
cycl
equival
dna
amount
oocyst
wherea
valu
immunis
mice
cycl
equival
dna
amount
oocyst
first
exampl
effect
prevent
neonat
extens
appli
part
matern
neonat
tetanu
elimin
mnte
program
success
immunis
also
achiev
influenza
viru
acellular
pertussi
antigen
vaccin
protect
infant
clinic
pertussi
therefor
matern
immunis
effect
strategi
limit
neonat
cryptosporidiosi
develop
matur
immun
system
peptid
enhanc
humor
cellmedi
immun
respons
c
parvum
adult
mice
mucos
immunis
pregnant
mice
mixtur
antigen
mix
result
remark
reduct
parasit
load
gut
infect
offspr
overal
result
repres
proof
concept
matern
immunis
effect
prevent
neonat
cryptosporidiosi
